About Julphar

Julphar (Gulf Pharmaceutical Industries PSC) is one of the largest pharmaceutical manufacturers in the Middle East and Africa. The company was established in 1980 under His Highness Sheikh Saqr Bin Mohammed Al Qasimi, the late ruler of Ras Al Khaimah. For over four decades, Julphar has been delivering high-quality, innovative, and affordable healthcare solutions to families across the globe. Following a strategic transformation to strengthen and focus its core operations, Julphar manufactures and markets a broad portfolio of pharmaceutical products targeting major therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Anti-infectives, Anemia, Gynecology, Dermatology, Cardiology, and other essential therapeutic areas. Listed on the Abu Dhabi Securities Exchange (ADX), Julphar continues to invest in manufacturing excellence, quality assurance, and market expansion, remaining committed to its founding mission of making quality healthcare accessible and affordable across the region and beyond.